Affiliation:
1. Servicio de Microbiología, Hospital Universitario Ramón y Cajal, 28034 Madrid
2. Departamento de Microbiología, Facultad de Medicina, Universidad de Sevilla
3. Servicio de Microbiología, Hospital Universitario Virgen Macarena, 41009 Seville, Spain
Abstract
ABSTRACT
Eighteen
Enterobacteriaceae
and
Pseudomonas aeruginosa
strains, 16 of them with well-defined β-lactam re sistance mechanisms, were sent to 52 Spanish microbiology laboratories. Interpretative categories for 8 extended-spectrum β-lactams were collected. Participating laboratories used their own routine susceptibility testing procedures (88% automatic systems, 10% disk diffusion, and 2% agar dilution). Control results were established by two independent reference laboratories by applying the NCCLS microdilution method and interpretative criteria. Interpretative discrepancies were observed in 16% of the results (4.4% for cefepime, 3.0% for aztreonam, 2.8% for piperacillin-tazobactam, 1.7% for cefotaxime [CTX] and ceftazidime, 1.1% for ceftriaxone, 0.9% for meropenem, and 0.3% for imipenem). High consistency with reference values (<5% of major plus very major errors) was observed with (i) American Type Culture Collection quality control strains; (ii) strains with low-efficiency mechanisms inactivating extended-spectrum β-lactams, such as OXA-1-producing
Escherichiacoli
or SHV-1-hyperproducing
Klebsiella pneumoniae
; (iii) strains with highly efficient mechanisms, such as SHV-5 porin-deficient
K. pneumoniae
, CTX-M-10 in
Enterobacter cloacae
hyperproducing AmpC, and
P. aeruginosa
with the MexAB OprM efflux phenotype or hyperproducing AmpC. Low consistency (>30% major plus very major errors) was detected in K1-producing
Klebsiella oxytoca
, CTX-M-9-producing
E. coli
, and in OprD
−
P. aeruginosa
strains. Extended-spectrum β-lactamase (ESBL)-producing strains accounted for 86% of very major errors. Recognition of the ESBL phenotype was particularly low in
Enterobacter cloacae
strains (<35%), due to the lack of NCCLS-specific rules in this genus. A K1-producing
K. oxytoca
was misidentified by 10% of laboratories as an ESBL producer. The use of well-defined resistant strains is useful for improving proficiency in susceptibility testing in clinical laboratories.
Publisher
American Society for Microbiology
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献